| scholarly article | Q13442814 |
| P50 | author | Hyunsu Bae | Q39839135 |
| P2093 | author name string | Chanju Lee | |
| Jayoung Oh | |||
| Hyunju Jeong | |||
| Sinwoo Kang | |||
| Hwikyung Kim | |||
| Kyungmoon Shin | |||
| Younghyeon Bae | |||
| P2860 | cites work | Exploring the full spectrum of macrophage activation | Q24653754 |
| Alternative activation of macrophages | Q27860939 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Macrophages, innate immunity and cancer: balance, tolerance, and diversity | Q29614352 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy | Q29618033 | ||
| Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. | Q30829636 | ||
| CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. | Q34279134 | ||
| Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages | Q34571570 | ||
| Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
| Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3. | Q34787668 | ||
| Tumor-associated macrophages: a molecular perspective | Q34913486 | ||
| M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma | Q35473223 | ||
| Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms | Q35674290 | ||
| Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance | Q35903509 | ||
| Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy | Q36414978 | ||
| Role of tumor-associated macrophages in tumor progression and invasion | Q36591374 | ||
| Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy | Q37258307 | ||
| Identification and manipulation of tumor associated macrophages in human cancers | Q37969227 | ||
| Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death | Q38040787 | ||
| Clinical significance of macrophage heterogeneity in human malignant tumors | Q38156195 | ||
| Learning from PD-1 Resistance: New Combination Strategies. | Q50513362 | ||
| The interaction of bee melittin with lipid bilayer membranes | Q52429706 | ||
| A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. | Q52573063 | ||
| All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. | Q54311933 | ||
| A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors | Q58450373 | ||
| A proapoptotic peptide for the treatment of solid tumors | Q77112307 | ||
| Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation | Q81377946 | ||
| Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells | Q81767144 | ||
| Labeling mitochondria with MitoTracker dyes | Q84637442 | ||
| Macrophage activation and its role in repair and pathology after spinal cord injury | Q38314167 | ||
| Immune-related adverse events with immune checkpoint blockade: a comprehensive review | Q38696141 | ||
| High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer. | Q38748794 | ||
| The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH. | Q39544225 | ||
| Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. | Q39689403 | ||
| In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy | Q40218347 | ||
| Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis | Q40742367 | ||
| Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model | Q41550052 | ||
| Anti-cancer activity of targeted pro-apoptotic peptides | Q41688099 | ||
| Melittin and the 8-26 fragment. Differences in ionophoric properties as measured by monolayer method | Q41810376 | ||
| Assessing bioenergetic function in response to oxidative stress by metabolic profiling | Q41816998 | ||
| De novo antimicrobial peptides with low mammalian cell toxicity | Q42810129 | ||
| The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis | Q43560476 | ||
| Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide. | Q46125533 | ||
| Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. | Q46189905 | ||
| Synthesis and biological characterisation of targeted pro-apoptotic peptide. | Q46422676 | ||
| Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment | Q47146426 | ||
| Macrophages orchestrate breast cancer early dissemination and metastasis. | Q47217923 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 147 | |
| P577 | publication date | 2019-06-07 | |
| P1433 | published in | Journal for Immunotherapy of Cancer | Q27725163 |
| P1476 | title | Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide. | |
| P478 | volume | 7 |
| Q102219632 | 3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions |
| Q92882400 | Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities |
| Q97645032 | CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q98771240 | LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness |
| Q90690112 | Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype |
| Q92760428 | Peptide-based targeting of immunosuppressive cells in cancer |
| Q99709001 | SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer |
| Q99617225 | Targeting tumor-associated macrophages in the tumor microenvironment |
| Q97524894 | Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer |
| Q91779671 | Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer |
Search more.